期刊文献+

SD大鼠扩张型心肌病模型的建立 被引量:14

Dilated cardiomyopathy induced by adriamycin in SD rats
下载PDF
导出
摘要 目的:探讨用多柔比星腹腔注射建立扩张型心肌病模型的可行性。方法:取10周龄雄性SD大鼠(350±50)g,共40只。随机分为4组:对照组、低剂量组、中剂量组、高剂量组,给药组腹腔注射量分别为8、16、24 mg/kg,并于给药前及给药后第2、4、6、8周用心脏超声观察收缩期、舒张末期内径及射血分数;第9周取心肌观察病理形态特征结果:心脏超声检查显示给药8周后中、高剂量组大鼠左心室收缩期末口径及舒张期末口径增大,左心室射血分数下降(P<0.05);组织病理检查符合扩张型心肌典型病理特征,但高剂量组大鼠生存率较低。结论:予以大鼠多柔比星腹腔注射每周2 mg/kg,8周可建立扩张型心肌病实验模型。 Objective: To investigate the feasibility to establish experimental model of dilated cardiomyopathy. Methods: Forty male 10 weeks old SD rats (350 :t: 50) g were randomly divided to 4 groups : control group, low dose group, middle dose group and high dose group. By the toxicity of adriamyein, different doses of adriamyein were given to rats by intraperitoneally injected. The left ventrieular dimensions at endsystole and end-diastole (LVDs, LVDd) and the ejection fraction (EF) were measured by eehoeardio- graphy at the 2^eh, 4^th, 6^th, 8^th weeks. Histopathological characteristics were observed at the 9^th week. Results: LYDD and LVDS in middle dose group and high dose group were significantly increased, and EF were significantly reduced ( P 〈 0.05 ) in these two groups compared with those rats in control group. Cardiac histopat.hological characteristics were similar to those of human dilated cardiomyopathy at the 9^th weeks in middle and high dose groups. Conclusion: SD rats with adriamycin intraperitoneally injected (2 mg/kg,8 weeks may be a desirable experimental model of dilated cardiomyopathy.
出处 《江苏大学学报(医学版)》 CAS 2006年第3期210-212,F0006,共4页 Journal of Jiangsu University:Medicine Edition
关键词 多柔比星 扩张型心肌病 SD大鼠 abdominal cardiomyopathy SD rat
  • 相关文献

参考文献9

  • 1Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies[J].Circulation,1996,93(5):841 -842.
  • 2Devereux RB,Reichek N,Echocardiographic determinition of left ventricular mass in man:Anatomic validation of the method[J].Circulation,1977,55 (4):613-618.
  • 3Hang Z,Li S,Chan R,et al.Astragaloside alleviates myocarditis fibrosis in murine CVB3 myocarditis[J].Chin J New Drugs Clin Rem,2003,32 (2):132 -139.
  • 4Kuhn H,Lawrenz T.Indication for myocardial biopsy in myocarditis and dilated cardiomyopathy[J].Med Klin,2005,100(9):553 -561.
  • 5李国草,李庚山,张静,周青,李文强.兔扩张型心肌病模型的复制[J].岭南心血管病杂志,2004,10(1):54-56. 被引量:5
  • 6白融,吕加高,卜军,周强,刘念,阮燕菲,王晨,罗惠珍,王琳.快速心室起搏制备扩张型心肌病心力衰竭犬模型的方法学探讨[J].中国实验动物学报,2004,12(3):159-162. 被引量:10
  • 7Teraoka K,Hirano M,Yamaguchi K,et al.Progressive cardiac dysfunction in adriamycin -induced cardiomyopathy rats[J].Eur J Heart Fail,2000,2(4):373 -378.
  • 8李双杰,张召才,陈瑞珍,杨英珍,陈灏珠,葛均波.Balb/c小鼠CVB_3病毒性扩张型心肌病并心力衰竭模型的建立[J].复旦学报(医学版),2004,31(6):559-561. 被引量:10
  • 9Berk F,Isgoren S,Demir H,et al.Evaluation of left ventricular function and volume in patients with dilated cardiomyopathy:gated myocardial single-photon emission tomography (SPECT) versus echocardiography[J].Ann Saudi Med,2005,25 (3):198-204.

二级参考文献17

  • 1[1]Takagaki M, McCarthy PM, Tabata T, et al. Induction and maintenance of an experimental model of severe cardiomyopahty with a novel protocol of rapid ventricular pacing[J]. J Thorc Cardiovasc Surg, 2002,123(3):544-549.
  • 2[2]Pagel PS, Hsttrick DA, Kersten JR, et al. Dexmedetomidine produces similar alterations in the determinants of left ventricular afterload in conscious dogs before and after the development of pacing-induced cardiomyopathy[J]. Ethesiology, 1998,89(3):741-748.
  • 3[5]Prabhu SS, Dalvi BV. Treatable cardiomyopathies[J]. Indian J Pediatr, 2000,67(3 Suppl):S7-S10.
  • 4[6]Fenelon G, Wijns W, Andries E, et al. Tachycardiomyopathy: mechanisms and clinical implications[J]. Pacing Clin Electrophysiol, 1996,19(1):95-106.
  • 5Cohn JN, Bristow MR, Chien KR, et al. Report of the national heart, lung and blood institute special emphasis panel on heart failure research. Circulation, 1997.95: 766
  • 6Liu PP, Mason JW. Advances in the understanding of myocarditis.Circulation, 2001,104:1076
  • 7Sole M J, Liu P. Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J Am Coll Cardiol, 1993,22: 99A
  • 8Wesselen L, Waldenstyom A, Lindblom B, et al. Genotypic and serotypic profile in dilated cardiomyopathy. Scand Infect Dis, 1993,88 (Suppl): 87
  • 9Zhang Z, Li S, Chan R, et al. Astragaloside alleviates myocarditis fibrosis in murine CVB3 myocarditis. Chin J New Drugs Clin Rem,2003,32(2): 132
  • 10Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death. Circulation, 1999,99:1091

共引文献17

同被引文献119

引证文献14

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部